Henry Stusnick

Henry Stusnick is an Analyst on the Investment Team at RA Capital Management, based in Boston, Massachusetts. In this capacity, he is responsible for supporting investment decisions across public and private healthcare and life science sectors, with a primary focus on biotech, pharmaceutical companies, and related therapeutics.

His role includes conducting fundamental analyses of companies in drug development, medical devices, diagnostics, and research tools, as well as serving as a Board Observer at Be Biopharma and Bluejay Therapeutics. This involvement signifies specialized expertise in early- and mid-stage biopharma investments and close engagement with portfolio companies developing innovative therapies.

Henry holds a degree from Dartmouth College and leverages a strong foundation in finance and the life sciences to contribute to strategic investment evaluations at RA Capital. His professional journey demonstrates a commitment to advancing transformative technologies in the healthcare investment ecosystem.